Life Technologies | Salgsomkostninger Og Administration



Selling And Administration Expenses Lave om Dato
Ardelyx USD 76.07M 11.1M 2024-12
Biogen USD 677.3M 99.6M 2024-12
Bristol-Myers Squibb USD 2.1B 129M 2024-12
Cipla INR 11.98B 102.6M 2024-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.73M 350K 2024-09
CSL USD 1.38B 341M 2024-06
Galapagos EUR 41.25M 11.98M 2024-12
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
Grifols EUR 269.48M 49.95M 2024-12
Life Technologies USD 3.34M 6K 2024-09
Novartis USD 3.5B 368M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
United Therapeutics USD 162.5M 8.4M 2024-12



Life Technologies Salgsomkostninger Og Administration - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.